Finding your GLP-1 maintenance dose is a structured experiment, not a guess, and the framework is simple: stabilize at goal, step down one increment at a time, hold each level for 4 to 8 weeks, and let two numbers (trend weight and hunger score) decide whether you step again or stop.<\/p>\n
Nobody can tell you your maintenance dose in advance. Trials established loss-phase dosing, but maintenance dosing has never been standardized in a published protocol, and individual variation is large. Some people hold their results on a quarter of their peak dose. Others need most of it. The only way to learn which person you are is to run the experiment carefully.<\/p>\n
The phrase “self-titration” needs an immediate disclaimer. You do not change your own prescription. You run the monitoring, collect the data, and bring a proposal to your prescriber, who makes every actual dose decision. Think of yourself as the research assistant and your doctor as the principal investigator.<\/p>\n
At TrimRx, we built our programs around exactly this kind of clinician-guided personalization. If you want a partner for the maintenance phase, the free assessment quiz takes about two minutes and starts that conversation.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
Because the trials were designed to measure loss, not to find the smallest dose that preserves it.<\/strong> The STEP program tested semaglutide 2.4 mg against placebo. SURMOUNT-1 (Jastreboff 2022, NEJM) tested tirzepatide at 5, 10, and 15 mg. Those studies answered “how much can people lose” convincingly, with average losses around 15 percent for semaglutide and up to about 21 percent for high-dose tirzepatide.<\/p>\n Quick Answer: Your maintenance dose of a GLP-1 is found, not assigned. There is no published standard, so the answer comes from a structured step-down run with your prescriber.<\/p>\n What they didn’t test was a step-down arm: take responders, reduce the dose, and see who holds. That trial hasn’t been published, so maintenance dosing lives in the space between pharmacology and clinical judgment.<\/p>\n Two facts frame the problem. First, full cessation has a documented cost: in the STEP 1 extension, participants regained about two-thirds of lost weight within a year off the drug. Second, lower doses clearly do real work, since semaglutide 1 mg and tirzepatide 5 mg both produce meaningful effects in trials. Somewhere between zero and your peak dose sits your personal floor. The framework exists to find it without losing ground in the process.<\/p>\n The stability gate is a simple rule: do not begin stepping down until you have held your goal weight within a 3-pound band for at least 8 weeks at your current dose.<\/strong> Starting a titration experiment from an unstable baseline makes the results unreadable.<\/p>\n The reason is signal quality. If your weight is still drifting down, a dose reduction that slows the drift looks like success when it might be failure. If you just reached goal last week, you have no idea what your weight does at this dose under normal life conditions, holidays, travel, stress and all. Eight weeks of flat trend gives you a baseline worth comparing against.<\/p>\n Use the gate period productively. Lock in the habits that will carry more load at lower doses: protein around 1.2 to 1.6 grams per kilogram daily, 2 strength sessions per week, and a weigh-in routine you actually follow. Patients who enter a step-down with these systems running tend to find lower floors than patients leaning entirely on the medication.<\/p>\n Weekly trend weight and a hunger score.<\/strong> Everything else is commentary. The trend weight tells you whether the current dose is holding your result. The hunger score tells you whether it is about to stop holding, usually 2 to 3 weeks before the scale knows.<\/p>\n Trend weight means averaging your weigh-ins across a week and comparing weekly averages, not reacting to single mornings. Daily weight swings 2 to 4 pounds on water, sodium, and digestion alone, which is pure noise. Weigh daily or at least 3 times weekly, same time, same conditions, and look only at the weekly average.<\/p>\n The hunger score is a 1-to-10 rating logged twice a week answering one question: how loud is food in my head today? A 2 means you forget to eat lunch. An 8 means you are thinking about snacks during meetings. The score sounds unscientific, but appetite rebound is the actual mechanism of regain, and it shows up in subjective experience weeks before it shows up in pounds. Rising scores are your early warning system.<\/p>\n One increment, roughly a 20 to 25 percent reduction, and never more than one step at a time.<\/strong> The goal is to keep each change small enough that a failure costs you 2 to 4 pounds, not 10.<\/p>\n What an increment looks like depends on your medication format. Brand pens come in fixed rungs, so your step is whatever the next rung down is, which can be a big jump. Compounded semaglutide and tirzepatide from 503A pharmacies are dispensed in vials and dosed by units, so your prescriber can write genuinely small decrements and even split the difference between standard levels. This flexibility is the main reason fine titration is practical at all, and it is one of the legitimate advantages of personalized compounded programs.<\/p>\n Resist the temptation to cut faster because the first step went well. Early steps often succeed because you are still far above your floor. The experiment gets informative, and risky, near the bottom. Slow is smooth.<\/p>\n Four to 8 weeks per level, with 6 as a sensible default.<\/strong> Shorter holds cannot separate signal from noise. A weekly trend needs at least 4 data points to mean anything, and the appetite effects of a dose change take 2 to 3 weeks to fully express because of the long half-life of these drugs.<\/p>\n Semaglutide has a half-life around one week, so after a dose reduction your blood levels glide down over several weeks rather than stepping down instantly. The hunger you feel in week 1 at a new dose is mostly the old dose talking. Judge nothing before week 3.<\/p>\n Extend the hold toward 8 weeks when life is noisy: vacations, holidays, illness, a stressful project. A hold that spans Thanksgiving will read badly for reasons that have nothing to do with pharmacology. If a hold gets contaminated by circumstances, do not step down on schedule. Repeat the hold. The framework has no deadline, and rushing it is the only real way to break it.<\/p>\n Key Takeaway: The STEP 1 extension showed roughly two-thirds of lost weight returning within a year of full cessation, which is why the framework finds a floor instead of racing to zero.<\/p>\n A hold passes when trend weight stays within your buffer (3 to 5 pounds above goal) and hunger scores stay manageable, meaning no sustained climb and no return of constant food noise.<\/strong> Pass both, and you propose the next step down. Fail either, and you go back up one level.<\/p>\n Write the criteria before the hold starts. Deciding what counts as failure while you are in the middle of one invites rationalization in both directions. Some people excuse a climbing trend (“it is just water”), others panic at noise (“I gained 2 pounds overnight”). Pre-written rules protect you from both.<\/p>\n A failed hold is a successful experiment. It found your floor, which was the entire point. Return to the previous level, confirm your weight restabilizes over 4 to 6 weeks, and call that dose your maintenance floor. Most clinicians suggest sitting at the floor for 3 to 6 months before any retest, and many patients never need to retest at all.<\/p>\n Short, data-driven, and scheduled in advance.<\/strong> The framework gives your prescriber exactly what they need to make fast, confident decisions: a trend chart, hunger scores, and a specific proposal. A check-in that starts with “weight stable for 6 weeks, hunger scores 2 to 3, requesting step from 1.0 to 0.75” takes five minutes and usually ends in agreement.<\/p>\n Set the cadence up front. A common pattern is a visit or message check-in at the end of each hold, so dose changes happen at planned moments rather than ad hoc. Telehealth makes this easy, and asynchronous messaging works fine for routine steps as long as your prescriber has the data.<\/p>\n Bring the failures too. A hold that failed is not an embarrassing confession, it is the key data point of the whole project. Prescribers who see honest numbers can also catch things you might miss: a new medication that stimulates appetite, a sleep problem masquerading as dose failure, labs worth checking.<\/p>\n Five mistakes account for most failed step-downs: skipping the stability gate, cutting two increments at once, judging a hold in week 1, ignoring hunger scores until the scale moves, and treating zero as the goal.<\/strong> Every one of them trades patience for speed and pays for it in regain.<\/p>\n The zero-as-goal mistake deserves special attention. The framework finds your lowest effective dose, and for many people that number is not zero. Treating the floor as a waypoint on the path to quitting reintroduces all the cessation risk the framework was designed to avoid. If you and your doctor eventually decide to attempt full discontinuation, that is a separate decision with its own risk discussion, not an automatic final step.<\/p>\n One more quiet failure mode: pausing the monitoring once things feel stable. The two signals are the framework. When the logging stops, you are not maintaining a dose, you are drifting at one.<\/p>\n Run the framework once, carefully, and you walk away with something most patients never get: a number you trust, found from your own data, endorsed by your own doctor.<\/strong> That number turns the endless “should I still be on this much?” question into a settled fact you revisit twice a year.<\/p>\n This is also exactly the kind of work a good telehealth program should do with you, not leave you to improvise. TrimRx pairs compounded semaglutide and tirzepatide, with the fine dose increments that make real titration possible, with clinician check-ins built for the maintenance phase. If you are at or near goal and want a structured partner for the step-down, take the free assessment quiz and bring this framework to the first conversation.<\/p>\n Your maintenance dose exists. Go find it properly.<\/p>\n Bottom line: “Self-titration” means you gather the data and propose the move. Your doctor approves every dose change. That division of labor is the whole framework.<\/p>\n There is no published standard, and the honest range is wide. In clinical practice, many patients hold their results between 25 and 50 percent of their peak loss-phase dose, while some need nearly full dose and a minority do well even lower. Your floor depends on your biology, habits, and history, which is exactly why the step-down framework exists.<\/p>\n No. Every dose change is a prescribing decision, and the framework explicitly assigns those decisions to your clinician. What you own is the monitoring: trend weight, hunger scores, and the proposal you bring to each check-in. Patients who try to titrate alone also lose the safety net of a second set of eyes on confounders like new medications or lab changes.<\/p>\n Plan on 4 to 8 months for a full step-down from a peak dose, assuming 6-week holds and 3 to 4 steps. It feels slow until you compare it with the alternative: quitting outright, regaining over a year, and re-titrating from scratch. The framework is the faster path measured over any honest time horizon.<\/p>\n Confirm it on the weekly trend (not a single weigh-in), and if you cross your pre-written buffer of 3 to 5 pounds, return to the previous dose level. That previous level becomes your floor. Most regains caught this early reverse within a few weeks of stepping back up, which is precisely why the framework uses small steps and constant monitoring.<\/p>\n Because appetite moves first. The hunger and food noise rebound that drives regain shows up in subjective experience 2 to 3 weeks before it accumulates into pounds. A rising hunger score during a hold tells you the current dose is below your floor while the damage is still nearly zero. The scale alone tells you the same thing 3 weeks and several pounds later.<\/p>\n The structure is identical, but the increments and timelines differ slightly. Tirzepatide has a somewhat shorter half-life (around 5 days versus 7), and its standard dose ladder has different rungs. Compounded versions of both allow finer steps than pens. Your prescriber sets the specific increments; the gate, holds, signals, and pass\/fail rules stay the same.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" Introduction Finding your GLP-1 maintenance dose is a structured experiment, not a guess, and the framework is simple: stabilize at goal, step down one…<\/p>\n","protected":false},"author":11,"featured_media":106519,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[],"class_list":["post-106520","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/106520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=106520"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/106520\/revisions"}],"predecessor-version":[{"id":108119,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/106520\/revisions\/108119"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/106519"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=106520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=106520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=106520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Is the Stability Gate, and Why Does It Come First?<\/h2>\n
What Are the Two Signals That Drive Every Decision?<\/h2>\n
How Big Should Each STEP Down Be?<\/h2>\n
How Long Should You Hold at Each Level?<\/h2>\n
What Are the Pass\/fail Criteria for Each Hold?<\/h2>\n
What Does the Conversation with Your Doctor Look Like?<\/h2>\n
What Mistakes Break the Framework?<\/h2>\n
The Path Forward<\/h2>\n
FAQ<\/h2>\n
What Is a Typical GLP-1 Maintenance Dose After Weight Loss?<\/h3>\n
Can I Run This Framework Without a Doctor?<\/h3>\n
How Long Does It Take to Find a Maintenance Dose?<\/h3>\n
What If My Weight Rises During a Hold?<\/h3>\n
Why Do Hunger Scores Matter If I Weigh Myself Daily?<\/h3>\n
Does This Framework Work the Same for Semaglutide and Tirzepatide?<\/h3>\n